[Department of Error] Department of Error
Source 柳叶刀 Lancetjust now
Summary
Slomovitz BM, Zhu J, Yin R, et al. First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recur…
We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.
Open original- Desk
- Health
- Region
- United Kingdom
- Language
- English
- Item ID
- health-a4a1a2f9
Comments 0 comments
No comments yet. Be the first.